Last updated on March 2018

Pediatric Peanut Allergy


Brief description of study

A randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability and immunologic effects of HAL-MPE1 subcutaneous immunotherapy in adult and pediatric subjects with peanut allergy.

Clinical Study Identifier: TX198894

Find a site near you

Start Over

Vital Prospects Clinical Research Institute, P.C.

7307 S. Yale Ave., Kelly Suite 209 Tulsa, OK USA
  Connect »